1. Home
  2. FDMT vs MPAA Comparison

FDMT vs MPAA Comparison

Compare FDMT & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDMT
  • MPAA
  • Stock Information
  • Founded
  • FDMT 2013
  • MPAA 1968
  • Country
  • FDMT United States
  • MPAA United States
  • Employees
  • FDMT N/A
  • MPAA N/A
  • Industry
  • FDMT Biotechnology: Pharmaceutical Preparations
  • MPAA Auto Parts:O.E.M.
  • Sector
  • FDMT Health Care
  • MPAA Consumer Discretionary
  • Exchange
  • FDMT Nasdaq
  • MPAA Nasdaq
  • Market Cap
  • FDMT 391.8M
  • MPAA 327.4M
  • IPO Year
  • FDMT 2020
  • MPAA 1994
  • Fundamental
  • Price
  • FDMT $10.58
  • MPAA $13.34
  • Analyst Decision
  • FDMT Strong Buy
  • MPAA
  • Analyst Count
  • FDMT 9
  • MPAA 0
  • Target Price
  • FDMT $30.33
  • MPAA N/A
  • AVG Volume (30 Days)
  • FDMT 894.9K
  • MPAA 238.3K
  • Earning Date
  • FDMT 11-10-2025
  • MPAA 11-10-2025
  • Dividend Yield
  • FDMT N/A
  • MPAA N/A
  • EPS Growth
  • FDMT N/A
  • MPAA N/A
  • EPS
  • FDMT N/A
  • MPAA 0.12
  • Revenue
  • FDMT $120,000.00
  • MPAA $789,115,000.00
  • Revenue This Year
  • FDMT $8,572.97
  • MPAA $10.44
  • Revenue Next Year
  • FDMT $6.05
  • MPAA $4.88
  • P/E Ratio
  • FDMT N/A
  • MPAA $110.29
  • Revenue Growth
  • FDMT 605.88
  • MPAA 6.72
  • 52 Week Low
  • FDMT $2.24
  • MPAA $5.38
  • 52 Week High
  • FDMT $12.34
  • MPAA $18.12
  • Technical
  • Relative Strength Index (RSI)
  • FDMT 51.91
  • MPAA 41.89
  • Support Level
  • FDMT $10.15
  • MPAA $12.41
  • Resistance Level
  • FDMT $11.18
  • MPAA $13.18
  • Average True Range (ATR)
  • FDMT 0.91
  • MPAA 1.01
  • MACD
  • FDMT -0.09
  • MPAA -0.11
  • Stochastic Oscillator
  • FDMT 44.55
  • MPAA 17.86

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

Share on Social Networks: